Harrow Health, Inc.
NASDAQ: HROW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark L. Baum
- Employees
- 382
- Headquarters
- Nashville, United States
- IPO year
- 2007
- Market cap
- $1.6B
- Website
- https://www.harrowinc.com
Loading HROW…
Loading profile data…Frequently asked questions about HROW
What does Harrow Health, Inc. (HROW) do?
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harro...
Where does HROW trade?
Harrow Health, Inc. (HROW) trades on the NASDAQ Global Market.
What sector is HROW in?
Harrow Health, Inc. (HROW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Harrow Health, Inc.?
Mark L. Baum is the chief executive officer of Harrow Health, Inc. (HROW).
Where is Harrow Health, Inc. headquartered?
Harrow Health, Inc. is headquartered in United States.
Does HROW pay a dividend?
Harrow Health, Inc. (HROW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HROW go public?
Harrow Health, Inc. (HROW) completed its initial public offering in 2007.